Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 30Rectal Neoplasms 21Esophageal Neoplasms 15Colorectal Neoplasms 15Pancreatic Neoplasms 12Lung Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Prostatic Neoplasms 10Adenocarcinoma Of Esophagus 9Stomach Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Head and Neck Neoplasms 8Sarcoma 7Esophageal Squamous Cell Carcinoma 7Neoplasms 5Colonic Neoplasms 5Central Nervous System Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Urinary Bladder Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Breast Neoplasms, Male 4Breast Carcinoma In Situ 4Brain Neoplasms 4Recurrence 3Neoplasm Metastasis 3Kidney Neoplasms 3Glioma 3Glioblastoma 3

Interventions

Ipilimumab 114pembrolizumab 95Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Melanoma × Neoadjuvant Therapy × Clear all
NCT00324727 2021-06-21

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Delcath Systems Inc.

Phase 3 Completed
93 enrolled
Dermatologic

Uveal Melanoma, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡